249 related articles for article (PubMed ID: 21547702)
1. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
[TBL] [Abstract][Full Text] [Related]
2. Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer.
Shimizu K; Okita R; Saisho S; Maeda A; Nojima Y; Nakata M
World J Surg Oncol; 2015 Sep; 13():291. PubMed ID: 26424708
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain.
Nobel TB; Dave N; Eljalby M; Xing X; Barbetta A; Hsu M; Tan KS; Janjigian Y; Bains MS; Sihag S; Jones DR; Molena D
Ann Thorac Surg; 2020 Feb; 109(2):329-336. PubMed ID: 31614136
[TBL] [Abstract][Full Text] [Related]
4. Oligometastases After Curative Esophagectomy Are Not One Size Fits All.
Nobel TB; Sihag S; Xing X; Eljalby M; Hsu M; Tan KS; Sewell DB; Bains MS; Janjigian Y; Wu A; Ku G; Jones DR; Molena D
Ann Thorac Surg; 2021 Dec; 112(6):1775-1781. PubMed ID: 33689743
[TBL] [Abstract][Full Text] [Related]
5. Surgery Adherence and Survival Outcomes in Patients With Locally Advanced (IIA-IVA) Cancer of the Lower Esophagus: A SEER Database-Based Study.
Liu J; Chen H; Wu C
Am Surg; 2024 Jun; 90(6):1463-1474. PubMed ID: 38532292
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma.
Chen C; Chen ZJ; Li WJ; Deng T; Le HB; Zhang YK; Zhang BJ
J Int Med Res; 2024 Apr; 52(4):3000605241245016. PubMed ID: 38661098
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Timing of Adjuvant Therapy on Survival After Esophagectomy.
Rhodin KE; Raman V; Jawitz OK; Tong BC; Harpole DH; D'Amico TA
Ann Thorac Surg; 2020 Sep; 110(3):1023-1029. PubMed ID: 32330471
[TBL] [Abstract][Full Text] [Related]
8. Identifying intense inflammatory subtype of esophageal squamous cell carcinoma using clustering approach.
Matsuda S; Hoshino S; Goto T; Kawakubo H; Takeuchi M; Kobayashi R; Nakamura K; Takeuchi H; Nishihara H; Kitagawa Y
Gen Thorac Cardiovasc Surg; 2024 Jun; 72(6):417-425. PubMed ID: 38294659
[TBL] [Abstract][Full Text] [Related]
9. Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.
Holmberg D; Gottlieb-Vedi E; Hedberg J; Lindblad M; Mattsson F; Lagergren J
BMC Cancer; 2023 Apr; 23(1):375. PubMed ID: 37098462
[TBL] [Abstract][Full Text] [Related]
10. Waiting to Operate: The Risk of Salvage Esophagectomy.
Boerner T; Harrington C; Tan KS; Adusumilli PS; Bains MS; Bott MJ; Downey RJ; Huang J; Ilson DH; Isbell JM; Janjigian YY; Park BJ; Rocco G; Rusch VW; Sihag S; Wu AJ; Jones DR; Molena D
Ann Surg; 2023 May; 277(5):781-788. PubMed ID: 36727949
[TBL] [Abstract][Full Text] [Related]
11. Rad51 and Systemic Inflammatory Indicators as Novel Prognostic Markers in Esophageal Squamous Cell Carcinoma.
Wu N; Song Y; Zhu Y; Pang L; Chen Z; Chen X
Technol Cancer Res Treat; 2024; 23():15330338231216333. PubMed ID: 38258400
[TBL] [Abstract][Full Text] [Related]
12. Profiles of patient and tumour characteristics in relation to health-related quality of life after oesophageal cancer surgery.
Anandavadivelan P; Wikman A; Johar A; Lagergren P
PLoS One; 2018; 13(4):e0196187. PubMed ID: 29708994
[TBL] [Abstract][Full Text] [Related]
13. Esophageal surgical Apgar score (eSAS): A predictor for postoperative morbidity in patients undergoing neoadjuvant therapy and esophagectomy.
Wang Q; Zhang C; Qi C; Qiang Y; Zhang Z; Xu F; Shen Y
Thorac Cancer; 2024 Apr; 15(10):755-763. PubMed ID: 38390683
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life trajectories up to 15 years after curative treatment for esophageal cancer: a prospective cohort study.
Cheng Z; Johar A; Lagergren J; Schandl A; Lagergren P
Int J Surg; 2024 Mar; 110(3):1537-1545. PubMed ID: 38116704
[TBL] [Abstract][Full Text] [Related]
15. Body Composition and Clinical Outcomes in Esophageal Cancer Patients Treated with Immune Checkpoint Inhibitors.
Kosumi K; Baba Y; Hara Y; Wang H; Nomoto D; Toihata T; Ohuchi M; Harada K; Eto K; Ogawa K; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Baba H
Ann Surg Oncol; 2024 Jun; 31(6):3839-3849. PubMed ID: 38421531
[TBL] [Abstract][Full Text] [Related]
16. Predictive role of Naples prognostic score for survival in esophageal cancer: A meta-analysis.
Guo H; Wang T
Medicine (Baltimore); 2024 May; 103(21):e38160. PubMed ID: 38787991
[TBL] [Abstract][Full Text] [Related]
17. The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature.
Schizas D; Lazaridis II; Moris D; Mastoraki A; Lazaridis LD; Tsilimigras DI; Charalampakis N; Liakakos T
World J Surg Oncol; 2018 Mar; 16(1):55. PubMed ID: 29540179
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure.
Benites-Zapata VA; Hernandez AV; Nagarajan V; Cauthen CA; Starling RC; Tang WH
Am J Cardiol; 2015 Jan; 115(1):57-61. PubMed ID: 25456873
[TBL] [Abstract][Full Text] [Related]
19. Esophageal cancer in octogenarians: Should esophagectomy be done?
Cooper L; Orgad R; Levi Y; Shmilovitch H; Feferman Y; Solomon D; Kashtan H
J Geriatr Oncol; 2024 Mar; 15(2):101710. PubMed ID: 38281389
[TBL] [Abstract][Full Text] [Related]
20. Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.
Baum YS; Patil D; Huang JH; Spetka S; Torlak M; Nieh PT; Alemozaffar M; Ogan K; Master VA
Asian J Urol; 2016 Jan; 3(1):20-25. PubMed ID: 29264158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
